DHX30-related Neurodevelopmental Disorder (NEDMIAL)

DHX30-related Neurodevelopmental Disorder (NEDMIAL) is a neurodevelopmental disorder typically characterized by severe global delay, absent or minimal speech, marked motor impairment, hypotonia, feeding difficulty and abnormal gait. Seizures, movement disorder, microcephaly and brain abnormalities occur variably.

Genetics

The classic severe phenotype is usually caused by de novo heterozygous missense variants in conserved motifs of the DHX30 helicase core. Haploinsufficiency, non-core variants and rare biallelic variants can produce distinct or milder phenotypes.

Molecular Mechanism

DHX30 is an ATP-dependent RNA helicase involved in ribosome biogenesis, translation, stress-granule dynamics and RNA metabolism. Helicase-core variants reduce ATPase and unwinding activity and can act dominantly to impair global translation and cellular stress responses.

Therapy

No disease-modifying treatment exists. Care is multidisciplinary and addresses epilepsy, nutrition and swallowing, communication, tone, mobility, orthopedic complications and sleep.

CCP Activity

CCP designs and plans comprehensive characterization of a DHX30 disease model, including neurobehavioral, electrophysiological (EEG) phenotyping with comprehensive physiological assessment. The immediate goal is a robust natural-history and endpoint framework for future intervention studies.

Mouse Models Mouse Models & Gene Cards

Mouse ModelsGene Cards
TBDTBD